Doxycycline directly targets PAR1 to suppress tumor progression.
Zhong W, Chen S, Zhang Q, Xiao T, Qin Y, Gu J, Sun B, Liu Y, Jing X, Hu X, Zhang P, Zhou H, Sun T, Yang C.
Zhong W, et al. Among authors: sun b, sun t.
Oncotarget. 2017 Mar 7;8(10):16829-16842. doi: 10.18632/oncotarget.15166.
Oncotarget. 2017.
PMID: 28187433
Free PMC article.